Durham's Patheon puts itself closer to customers in North America

When Jim Mullen, CEO of Patheon Pharma’s parent holding company, started thinking about an acquisition in the United States, it wasn’t a question of “if,” but “whom?” Patheon, a contract manufacturer of pharmaceutical products, had production facilities in Australia and the Netherlands, but nothing closer to North America where many of its customers are based...